Page 2 - Tim Dyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim dyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Dyer Today - Breaking & Trending Today

Addex's Janssen-partnered epilepsy drug fails phase 2 trial

Addex's Janssen-partnered epilepsy drug fails phase 2 trial
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Tim Dyer , Roger Mills , Addex Therapeutic , Fierce Biotech , Medical Officer Roger Mills , Nasdaq Capital Market , Perceptive Advisors ,

Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks

Monday, Addex Therapeutics (NASDAQ:ADXN) released top-line data from a Phase 2 epilepsy study evaluating adjunctive ADX71149 (JNJ-40411813) administration in patients with focal onset seizures with suboptimal response to levetiracetam or brivaracetam. The company is collaborating with Johnson & Johnson’s (NYSE:JNJ) Janssen Pharmaceuticals Inc. The Phase 2 study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was ....

Roger Mills , Tim Dyer , Janssen Pharmaceuticals Inc , Addex Therapeutics , Janssen Pharmaceuticals , Chief Medical Officer , Stock Market Game , Benzinga Pro , Day Trial , Stock Tanks , Roger Mills , Statistical Significance , Janssen Pharmaceuticals Inc , Chief Medical Officer ,

Addex To Present At The Swiss Biotech Day 2024

Addex To Present At The Swiss Biotech Day 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Tim Dyer , Congress Center , Swiss Biotech Day ,

Addex to Present at the Swiss Biotech Day 2024

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will. ....

United States , Mike Sinclair , Tim Dyer , Janssen Pharmaceuticals Inc , Congress Center , Swiss Exchange , Swiss Biotech Day , Addex Therapeutics , Janssen Pharmaceuticals , American Depositary Shares , Executive Officer , Halsin Partners , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Tim Dyer , Mike Sinclair , Mikhail Kalinichev , Swiss Exchange , Janssen Pharmaceuticals Inc , Release Full Year , Host Conference Call , Addex Therapeutics , Translational Science , Conference Call , Participant Dial In , Janssen Pharmaceuticals , American Depositary Shares , Executive Officer , Halsin Partners , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,